Abstract

LANGUAGE NOTE | Document text in Chinese; abstract also in English. In this paper, I first reiterate the views of Lyreskog et al. and stress the importance of discussing ethical questions in the context of ABT—a topic that has clearly not received enough attention in China. Second, given the current state of Chinese applied ethics, I focus on what Lyreskog et al. refer to as a “seismic shift in how we conceptualize much of what we take to be core values in medicine and healthcare” (Lyreskog et. al 2023, 11–34) to explain how to realize the innovative progress of ABT ethics in contemporary China. I agree in principle that frameworks aiming to offer ethical guidance in ABT situations should use ontologies and taxonomies that allow for conceptual flexibility and redesign. These frameworks should also be subjected to philosophical critique and modified in light of scientific practice.